$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Methods and formulations of cremophor-free taxanes 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/127
  • A61K-009/14
  • A61K-009/50
  • A61F-013/00
  • A61F-002/00
출원번호 US-0628388 (2000-08-01)
발명자 / 주소
  • Desai, Neil P.
  • Soon-Shiong, Patrick
출원인 / 주소
  • American BioScience, Inc.
대리인 / 주소
    Reiter, Stephen E.Foley & Lardner
인용정보 피인용 횟수 : 139  인용 특허 : 10

초록

In accordance with the present invention, there are provided composition and methods useful for the in vivo delivery of a pharmaceutically active agent, wherein the agent is associated with a polymeric biocompatible material.

대표청구항

In accordance with the present invention, there are provided composition and methods useful for the in vivo delivery of a pharmaceutically active agent, wherein the agent is associated with a polymeric biocompatible material.

이 특허에 인용된 특허 (10)

  1. Rahman Aquilur (Gaithersburg MD) Rafaeloff Rafael (Tel-Aviv ILX) Husain Syed Rafat (Gaithersburg MD), Liposome encapsulated toxol and a method of using the same.
  2. Desai Neil P. ; Soon-Shiong Patrick, Methods and compositions useful for administration of chemotherapeutic agents.
  3. Desai Neil P. (Los Angeles CA) Soon-Shiong Patrick (Los Angeles CA) Sandford Paul A. (Los Angeles CA) Grinstaff Mark W. (Pasadena CA) Suslick Kenneth S. (Champaign IL), Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful th.
  4. Desai Neil P. ; Tao Chunlin ; Yang Andrew ; Louie Leslie ; Zheng Tianli ; Yao Zhiwen ; Soon-Shiong Patrick ; Magdassi Shlomo,ILX, Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof.
  5. Webb Murray S. (Vancouver CAX) Bally Marcel B. (Bowen Island CAX) Mayer Lawrence D. (North Vancouver CAX), Sphingosomes for enhanced drug delivery.
  6. Agharkar Shreeram N. (Fayetteville NY) Gogate Uday S. (East Syracuse NY), Stabilized pharmaceutical composition and stabilizing solvent.
  7. Liversidge Gary G. (West Chester PA) Liversidge Elaine (West Chester PA) Sarpotdar Pramod P. (Malvern PA), Surface modified anticancer nanoparticles.
  8. Boni Lawrence (Monmouth Junction NJ) Portnoff Joel (Langhorne PA), Taxane-containing phosphatidylcholine liposomes.
  9. Martin Frederick H. (West Chazy NY) Tsuk Andrew G. (Plattsburgh NY), Therapeutic compositions with enhanced bioavailability.
  10. Li Chun ; Wallace Sidney ; Yu Dong-Fang ; Yang David J., Water soluble paclitaxel prodrugs.

이 특허를 인용한 특허 (139)

  1. Tao, Chunlin; Han, Hongna; Sun, Xiaowen; Desai, Neil; Soon-Shiong, Patrick, Analogs of ansamycin and pharmaceutical compositions thereof.
  2. Sabin,Robert, Anti tumor compositions and methods of use.
  3. Tao, Chunlin; Wang, Qinwei; Ho, David; Nallan, Laxman; Polat, Tulay; Sun, Xiaowen; Desai, Neil, Benzyl substituted triazine derivatives and their therapeutical applications.
  4. Tao, Chunlin; Wang, Qinwei; Ho, David; Nallan, Laxman; Polat, Tulay; Sun, Xiaowen; Desai, Neil, Benzyl substituted triazine derivatives and their therapeutical applications.
  5. Koya, Keizo; Sun, Lijun; Kostik, Elena; Vaghefi, Farid; Chen, Shoujun; Tatsuta, Noriaki; Liang, Guiqing; Inoue, Takayo; Xia, Zhi-Qiang, Bis(thio-hydrazide amide) salts for treatment of cancers.
  6. Koya, Keizo; Sun, Lijun; Kostik, Elena; Vaghefi, Farid; Chen, Shoujun; Tatsuta, Noriaki; Liang, Guiqing; Inoue, Takayo; Xia, Zhi-Qiang, Bis(thio-hydrazide amide) salts for treatment of cancers.
  7. Koya, Keizo; Sun, Lijun; Kostik, Elena; Vaghefi, Farid; Chen, Shoujun; Tatsuta, Noriaki; Liang, Guiqing; Inoue, Takayo; Xia, Zhi-Qiang, Bis(thio-hydrazide amide) salts for treatment of cancers.
  8. Desai, Neil P.; Soon-Shiong, Patrick, Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane.
  9. Desai, Neil P.; Soon-Shiong, Patrick, Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane.
  10. Desai, Neil P.; Soon-Shiong, Patrick, Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane.
  11. Gillies,Stephen D.; Stein,Pascal A.; Lo,Kin Ming, Cancer treatments including administering IL-2 fusion proteins with modulated selectivity.
  12. de los Rios, Miguel; de los Rios, Stephanie, Chimeric therapeutics, compositions, and methods for using same.
  13. Dahl, Thomas A.; McLeod, Matthew, Combination cancer therapy with bis(thiohydrazide) amide compounds.
  14. Desai, Neil P.; Soon-Shiong, Patrick, Combinations and modes of administration of therapeutic agents and combination therapy.
  15. Desai, Neil P.; Soon-Shiong, Patrick, Combinations and modes of administration of therapeutic agents and combination therapy.
  16. Desai, Neil P.; Soon-Shiong, Patrick, Combinations and modes of administration of therapeutic agents and combination therapy.
  17. Desai, Neil P.; Soon-Shiong, Patrick, Combinations and modes of administration of therapeutic agents and combination therapy.
  18. Desai, Neil P.; Soon-Shiong, Patrick, Combinations and modes of administration of therapeutic agents and combination therapy.
  19. Desai, Neil P.; Soon-Shiong, Patrick, Combinations and modes of administration of therapeutic agents and combination therapy.
  20. De, Tapas; Desai, Neil P.; Yang, Andrew; Yim, Zachary; Soon-Shiong, Patrick, Compositions and methods for preparation of poorly water soluble drugs with increased stability.
  21. De, Tapas; Desai, Neil P.; Yang, Andrew; Yim, Zachary; Soon-Shiong, Patrick, Compositions and methods for preparation of poorly water soluble drugs with increased stability.
  22. De, Tapas; Desai, Neil P; Yang, Andrew; Yim, Zachary; Soon-Shiong, Patrick, Compositions and methods for preparation of poorly water soluble drugs with increased stability.
  23. Davis, Claude Geoffrey; de los Rios, Miguel A.; Oh, Kenneth J.; Bullock, Timothy L.; Johnson, Patrick T.; Ostrowski, Jacek, Compositions and methods for treating B-cell malignancies.
  24. Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong, Compositions and methods of delivery of pharmacological agents.
  25. Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong, Compositions and methods of delivery of pharmacological agents.
  26. Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong, Compositions and methods of delivery of pharmacological agents.
  27. Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong, Compositions and methods of delivery of pharmacological agents.
  28. Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong, Compositions and methods of delivery of pharmacological agents.
  29. Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong, Compositions and methods of delivery of pharmacological agents.
  30. Desai, Neil P.; Selvaraj, Raj; Yang, Andrew; Soon-Shiong, Patrick, Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents.
  31. Van, Sang; Song, Yucheng; Wang, Xinghe; Hou, Zheng; Feng, Zhongling; Zhao, Gang; Yu, Lei, Compositions that include a hydrophobic compound and a polyamino acid conjugate.
  32. Van, Sang; Song, Yucheng; Wang, Xinghe; Hou, Zheng; Feng, Zhongling; Zhao, Gang; Yu, Lei, Compositions that include a hydrophobic compound and a polyamino acid conjugate.
  33. Desai, Neil P.; Tao, Chunlin; Yu, Cheng Zhi; Trieu, Vuong; Soon-Shiong, Patrick, Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury.
  34. Chen, Shoujun; Koya, Keizo; Demko, Zachary; Sun, Lijun, Compounds for treating proliferative disorders.
  35. Peyman, Gholam A., Crystalline lens drug delivery.
  36. Tao, Chunlin; Yu, Chengzhi; Arp, Forrest; Weingarten, Paul; Soon-Shiong, Patrick, Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway.
  37. Tao, Chunlin; Yu, Chengzhi; Arp, Forrest; Weingarten, Paul; Soon-Shiong, Patrick, Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway.
  38. Cheng, Jianjun; Davis, Mark E.; Khin, Kat T., Cyclodextrin-based polymers for therapeutics delivery.
  39. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  40. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  41. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  42. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  43. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  44. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  45. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  46. Cheng, Jianjun; Davis, Mark E.; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  47. Cheng, Jianjun; Davis, Mark; Khin, Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  48. Davis, Mark E.; Hwang, Jungyeon; Ke, Tianyi; Lim, Ching-Jou; Schluep, Thomas, Cyclodextrin-based polymers for therapeutics delivery.
  49. Gillies, Stephen D.; Stein, Pascal Andre; Lo, Kin-Ming, DNA encoding IL-2 fusion proteins with modulated selectivity.
  50. Soon-Shiong, Patrick; Desai, Neil P.; Tao, Chunlin; Yu, Cheng Zhi, Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications.
  51. Tao, Chunlin; Wang, Qinwei; Trieu, Vuong; Desai, Neil; Soon-Shiong, Patrick, Dicarbonyl derivatives and methods of use.
  52. Gillies, Stephen D.; Lan, Yan; Holden, Sylvia, Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents.
  53. Gillies, Stephen D.; Burger, Christa; Lo, Kin-Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  54. Gillies,Stephen D.; Burger,Christa; Lo,Kin Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  55. Gillies,Stephen D.; Burger,Christa; Lo,Kin Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  56. Way,Jeffrey, Erythropoietin forms with improved properties.
  57. Nebuloni, Marino; Colombo, Patrizia, Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride.
  58. Nebuloni, Marino; Colombo, Patrizia, Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride.
  59. Nebuloni, Marino; Colombo, Patrizia, Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride.
  60. Gillies,Stephen D.; Lo,Kin Ming, Expression technology for proteins containing a hybrid isotype antibody moiety.
  61. Gillies,Stephen D.; Lo,Kin Ming; Wesolowski, Jr.,John S., Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens.
  62. Desai, Neil P.; Soon-Shiong, Patrick, Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof.
  63. Desai, Neil P.; Tao, Chunlin; Yang, Andrew; Louie, Leslie; Soon-Shiong, Patrick, Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof.
  64. Sood, Anil K.; Lacko, Andras G.; Lopez-Berestein, Gabriel; Mangala, Lingegowda S.; McConathy, Walter J.; Prokai, Laszlo; Nair, Maya P., HDL particles for delivery of nucleic acids.
  65. Gillies, Stephen D.; Lo, Kin Ming; Lan, Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  66. Gillies, Stephen D.; Lo, Kin-Ming; Lan, Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  67. Gillies, Stephen D.; Lo, Kin-Ming; Lan, Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  68. Gillies,Stephen D.; Lo,Kin Ming; Lan,Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  69. Gillies,Stephen D.; Stein,Pascal A.; Lo,Kin Ming, IL-2 fusion proteins with modulated selectivity.
  70. Trieu, Vuong; De, Tapas K., Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods.
  71. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan X., Immunocytokine sequences and uses thereof.
  72. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan Xiuqi, Immunocytokine sequences and uses thereof.
  73. Gillies,Stephen D.; Lo,Kin Ming; Qian,Susan X., Immunocytokine sequences and uses thereof.
  74. Seward, Kirk; Desai, Neil P., Intravascular delivery of nanoparticle compositions and uses thereof.
  75. Seward, Kirk; Desai, Neil P., Intravascular delivery of nanoparticle compositions and uses thereof.
  76. Seward, Kirk; Desai, Neil P., Intravascular delivery of nanoparticle compositions and uses thereof.
  77. Tao, Chunlin; Sun, Xiaowen; Han, Hongna; Koroniak, Lukasz; Desai, Neil, Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling.
  78. Palepu, Nagesh; Kessler, Dean; Tustian, Alexander K.; Quay, Steven C.; Constantinides, Panayiotis P.; Lambert, Karel J., Method for treating colorectal carcinoma using a taxane/tocopherol formulation.
  79. de los Rios, Miguel; de los Rios, Stephanie; Ostrowski, Jacek; Oh, Kenneth J.; Zipkin, Ilan, Methods and compositions for controlling assembly of viral proteins.
  80. Lederman, Seth; Harris, Herb, Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine.
  81. Desai, Neil P.; Soon-Shiong, Patrick; De, Tapas, Methods and compositions for treating proliferative diseases.
  82. Desai, Neil P.; Soon-Shiong, Patrick; De, Tapas K., Methods and compositions for treating proliferative diseases.
  83. Desai, Neil P.; Soon-Shiong, Patrick, Methods and compositions for treating recurrent cancer.
  84. Lederman, Seth; Harris, Herbert, Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine.
  85. MacBeth, Kyle J.; Nguyen, Aaron N.; DiMartino, Jorge, Methods for treating cancers using oral formulations of cytidine analogs.
  86. MacBeth, Kyle J.; Nguyen, Aaron N.; Dimartino, Jorge, Methods for treating cancers using oral formulations of cytidine analogs.
  87. Yeo, Winnie; Wong, Nathalie, Methods for treating hepatocellular carcinoma.
  88. Gillies, Stephen D.; Lo, Kin Ming, Methods of targeting multiple cytokines.
  89. Desai, Neil P., Methods of treating bladder cancer.
  90. Desai, Neil P.; Soon-Shiong, Patrick, Methods of treating cancer.
  91. Desai, Neil P.; Soon-Shiong, Patrick, Methods of treating cancer.
  92. Desai, Neil P.; Renschler, Markus, Methods of treating melanoma.
  93. Desai, Neil P.; Renschler, Markus, Methods of treating pancreatic cancer.
  94. Desai, Neil P.; Renschler, Markus, Methods of treating pancreatic cancer.
  95. Desai, Neil P.; Soon-Shiong, Patrick, Methods of treatment of pancreatic cancer.
  96. Desai, Neil P.; Soon-Shiong, Patrick, Methods of treatment of pancreatic cancer.
  97. Desai, Neil P.; Soon-Shiong, Patrick, Methods of treatment of pancreatic cancer.
  98. Gillies, Stephen D.; Lo, Kin-Ming; Wesolowski, Jr., John S., Methods of using Fc-cytokine fusion proteins.
  99. Gillies,Stephen D.; Lo,Kin Ming, Multiple cytokine protein complexes.
  100. Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong, Nanoparticle comprising rapamycin and albumin as anticancer agent.
  101. Nabeta, Kiichiro, Non-aqueous taxane formulations and methods of using the same.
  102. Nabeta, Kiichiro, Non-aqueous taxane formulations and methods of using the same.
  103. Nabeta, Kiichiro, Non-aqueous taxane nanodispersion formulations and methods of using the same.
  104. Peyman,Gholam A., Ocular drainage device.
  105. Koya, Keizo; Sun, Lijun; Chen, Shoujun; Tatsuta, Noriaki; Wu, Yaming; Ono, Mitsunori; Xia, Zhi-Qiang, Paclitaxel enhancer compound.
  106. Koya, Keizo; Sun, Lijun; Chen, Shoujun; Tatsuta, Noriaki; Wu, Yaming; Ono, Mitsunori, Paclitaxel enhancer compounds.
  107. Koya, Keizo; Sun, Lijun; Chen, Shoujun; Tatsuta, Noriaki; Wu, Yaming; Ono, Mitsunori, Paclitaxel enhancer compounds.
  108. Cheng, Jianjun; Tong, Rong, Particulate drug delivery methods.
  109. Yu, Lei; Zhao, Gang; Van, Sang; Das, Sanjib Kumar; Feng, Zhongling; Fu, Xiaoli; Wang, Xinghe; Jin, Yi; Chen, Fu, Polyglutamate-amino acid conjugates and methods.
  110. Davis, Mark E.; Hwang, Jungyeon; Ke, Tianyi; Lim, Ching-jou; Schluep, Thomas, Polymer drug conjugates with tether groups for controlled drug delivery.
  111. Desai, Neil P.; Peykov, Viktor; Soon-Shiong, Patrick, Prion free nanoparticle compositions and methods of making thereof.
  112. Desai, Neil P.; Peykov, Viktor; Soon-Shiong, Patrick, Prion free nanoparticle compositions and methods of making thereof.
  113. Tao, Chunlin; Yu, Cheng Zhi; Desai, Neil P.; Trieu, Vuong, Propofol analogs, process for their preparation, and methods of use.
  114. Gillies, Stephen D.; Way, Jeffrey; Lo, Kin-Ming, Proteins comprising an IgG2 domain.
  115. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan X., Recombinant tumor specific antibody and use thereof.
  116. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan Xiuqi, Recombinant tumor specific antibody and use thereof.
  117. Gillies,Stephen D.; Lo,Kin Ming; Qian,Susan Xiuqi, Recombinant tumor specific antibody and use thereof.
  118. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  119. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  120. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  121. Gillies,Stephen D.; Hamilton,Anita A., Reducing the immunogenicity of fusion proteins.
  122. Tao, Chunlin, Substituted indol-5-ol derivatives and their therapeutic applications.
  123. Tao, Chunlin; Wang, Qinwei; Ho, David; Polat, Tulay; Nallan, Laxman; Soon-Shiong, Patrick, Substituted indol-5-ol derivatives and their therapeutic applications.
  124. Tao, Chunlin; Wang, Qinwei; Ho, David; Polat, Tulay; Nallan, Laxman; Soon-Shiong, Patrick, Substituted indol-5-ol derivatives and their therapeutical applications.
  125. Tao, Chunlin; Wang, Qinwei; Ho, David; Polat, Tulay; Nallan, Laxman; Soon-Shiong, Patrick, Substituted indol-5-ol derivatives and their therapeutical applications.
  126. Tao, Chunlin; Yu, Cheng-Zhi; Desai, Neil P.; Trieu, Vuong, Substituted melatonin derivatives, process for their preparation, and methods of use.
  127. Chen, Shoujun; Sun, Lijun; Xia, Zhi-Qiang; Kova, Keizo; Ono, Mitsunori, Synthesis of taxol enhancers.
  128. Kiichiro, Nabeta, Taxane pro-emulsion formulations and methods making and using the same.
  129. Head, Jonathan F.; Elliott, Robert L., Taxane- and taxoid-protein compositions.
  130. Koya, Keizo; Sun, Lijun; Wu, Yaming; Korbut, Timothy; Zhou, Dan; Du, Zhenjian; Chen, Shoujun; Tatsuta, Noriaki; Liang, Guiqing; Ono, Mitsunori, Treatment for cancers.
  131. Desai, Neil P.; Soon-Shiong, Patrick; Tao, Chunlin; Wang, Qinwei, Triazine derivatives and their therapeutical applications.
  132. Tao, Chunlin; Wang, Qinwei; Desai, Neil P.; Soon-Shiong, Patrick, Triazine derivatives and their therapeutical applications.
  133. Tao, Chunlin; Wang, Qinwei; Nallan, Laxman; Polat, Tulay; Ho, David; Desai, Neil, Triazine derivatives and their therapeutical applications.
  134. Ruoslahti, Erkki; Teesalu, Tambet; Sugahara, Kazuki; Roth, Lise, Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides.
  135. Au, Jessie L. S.; Wientjes, M. Guillaume, Tumor targeting drug-loaded particles.
  136. Hlavinka, Mark L.; Yang, Qing; Murph, Mandi Michelle, Use of metallocene compounds for cancer treatment.
  137. Hlavinka, Mark L.; Yang, Qing; Murph, Mandi Michelle, Use of metallocene compounds for cancer treatment.
  138. Foss, Willard; Shinde, Rajesh, Use of polymeric excipients for lyophilization or freezing of particles.
  139. Foss, Willard; Shinde, Rajesh, Use of polymeric excipients for lyophilization or freezing of particles.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로